Hosted on MSN8mon
Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly Says
A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleep apnea symptoms in obese adults, the company announced Wednesday, the latest findings ...
NBC New York21d
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
In June, Eli Lilly released additional data from the studies showing that Zepbound helped resolve ... to evaluate the severity of obstructive sleep apnea and the effectiveness of treatments ...
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
Mounjaro and other diabetes drugs are typically covered by insurance, while Zepbound and other weight loss drugs are not. But ...
ABC News21d
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...